Published in Neurology on June 12, 2007
Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain (2009) 2.38
Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy. Sci Transl Med (2012) 2.27
Genetic basis of limb-girdle muscular dystrophies: the 2014 update. Acta Myol (2014) 1.58
Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations. Eur J Hum Genet (2011) 1.16
How to tackle the diagnosis of limb-girdle muscular dystrophy 2A. Eur J Hum Genet (2008) 0.91
Phenotypic variability in siblings with calpainopathy (LGMD2A). Acta Myol (2008) 0.80
Plasma Membrane Repair: A Central Process for Maintaining Cellular Homeostasis. Physiology (Bethesda) (2015) 0.79
Autosomal recessive limb-girdle muscular dystrophies in the Czech Republic. BMC Neurol (2014) 0.78
Frequency of the FKRP mutation c.826C>A in isolated hyperCKemia and in limb girdle muscular dystrophy type 2 in German patients. J Neurol (2009) 0.77
Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med (1995) 5.16
Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet (1990) 4.99
Polymyositis: an overdiagnosed entity. Neurology (2003) 4.36
FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet (1993) 4.21
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet (1989) 3.81
Carpal tunnel syndrome: prevalence in the general population. J Clin Epidemiol (1992) 3.80
Estimating Y chromosome specific microsatellite mutation frequencies using deep rooting pedigrees. Hum Mol Genet (1997) 3.78
An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci (1983) 3.70
BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet (1997) 3.68
Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet (1997) 3.56
Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet (1996) 3.53
A deletion hot spot in the Duchenne muscular dystrophy gene. Genomics (1988) 3.18
Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy with closely linked RFLPs. Lancet (1985) 3.08
Isolation of probes detecting restriction fragment length polymorphisms from X chromosome-specific libraries: potential use for diagnosis of Duchenne muscular dystrophy. Hum Genet (1985) 3.08
Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene (1999) 3.00
The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys (1994) 2.97
POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J Med Genet (2005) 2.80
Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol (1995) 2.79
EAA/EMQN best practice guidelines for molecular diagnosis of y-chromosomal microdeletions. State of the art 2004. Int J Androl (2004) 2.70
Array-CGH detection of micro rearrangements in mentally retarded individuals: clinical significance of imbalances present both in affected children and normal parents. J Med Genet (2005) 2.60
Leukoencephalopathy with swelling and a discrepantly mild clinical course in eight children. Ann Neurol (1995) 2.57
Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet (2000) 2.52
Disorders of neuronal migration. Can J Neurol Sci (1987) 2.48
Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD). Neuromuscul Disord (2011) 2.47
Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by field inversion gels. Nature (1987) 2.44
Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol (2001) 2.43
Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Biophys Res Commun (2000) 2.40
Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy. Am J Hum Genet (1995) 2.33
Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol (1993) 2.25
The X chromosome shows less genetic variation at restriction sites than the autosomes. Am J Hum Genet (1986) 2.22
The Hoyeraal-Hreidarsson syndrome: the fourth case of a separate entity with prenatal growth retardation, progressive pancytopenia and cerebellar hypoplasia. Eur J Pediatr (1995) 2.19
[Guideline 'Diagnosis and treatment of carpal tunnel syndrome']. Ned Tijdschr Geneeskd (2008) 2.15
Efficacy of provocative tests for diagnosis of carpal tunnel syndrome. Lancet (1990) 2.15
A physical map of 4 million bp around the Duchenne muscular dystrophy gene on the human X-chromosome. Cell (1986) 2.12
Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet (1990) 2.09
Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet (1992) 2.04
Linkage of autosomal dominant hearing loss to the short arm of chromosome 1 in two families. N Engl J Med (1994) 2.03
Clinical features of facioscapulohumeral muscular dystrophy 2. Neurology (2010) 2.01
Phenotypic variation in leukoencephalopathy with vanishing white matter. Neurology (1998) 1.94
Diagnostic investigation of patients with chronic polyneuropathy: evaluation of a clinical guideline. J Neurol Neurosurg Psychiatry (2001) 1.92
Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet (1999) 1.92
Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science (1990) 1.92
Two subsets of human alphoid repetitive DNA show distinct preferential localization in the pericentric regions of chromosomes 13, 18, and 21. Cytogenet Cell Genet (1986) 1.90
A new leukoencephalopathy with vanishing white matter. Neurology (1997) 1.90
Long-range genomic map of the Duchenne muscular dystrophy (DMD) gene: isolation and use of J66 (DXS268), a distal intragenic marker. Genomics (1987) 1.89
Physical activity and the association with sporadic ALS. Neurology (2005) 1.89
Paraplegin mutations in sporadic adult-onset upper motor neuron syndromes. Neurology (2008) 1.86
Analysis of molecular variance (AMOVA) of Y-chromosome-specific microsatellites in two closely related human populations. Hum Mol Genet (1996) 1.84
Somatic APC mosaicism: an underestimated cause of polyposis coli. Gut (2007) 1.79
Phenotype of Charcot-Marie-Tooth disease Type 2. Neurology (2007) 1.79
Efficient isolation of X chromosome-specific single-copy probes from a cosmid library of a human X/hamster hybrid-cell line: mapping of new probes close to the locus for X-linked mental retardation. Am J Hum Genet (1987) 1.77
Risk factors for carpal tunnel syndrome. Am J Epidemiol (1990) 1.75
Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology (2004) 1.73
Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I. Ann Neurol (1999) 1.72
Evidence for subtelomeric exchange of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26: implications for genetic counselling and etiology of FSHD1. Hum Mol Genet (1996) 1.71
EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am J Hum Genet (1999) 1.70
An extensive analysis of Y-chromosomal microsatellite haplotypes in globally dispersed human populations. Am J Hum Genet (2001) 1.70
Potentiometric polymeric membrane electrodes for measurement of environmental samples at trace levels: new requirements for selectivities and measuring protocols, and comparison with ICPMS. Anal Chem (2001) 1.70
Diagnostic criteria for Duchenne and Becker muscular dystrophy and myotonic dystrophy. Neuromuscul Disord (1991) 1.68
The risk of intracerebral hemorrhage during oral anticoagulant treatment: a population study. Ann Neurol (1984) 1.63
Aicardi-Goutières syndrome: an update and results of interferon-alpha studies. Ann Neurol (1998) 1.61
Survival in SMA type I: a prospective analysis of 34 consecutive cases. Neuromuscul Disord (2008) 1.60
Anal dynamic graciloplasty in the treatment of intractable fecal incontinence. N Engl J Med (1995) 1.59
Cerebral haemorrhagic infarction in young patients with hereditary protein C deficiency: evidence for "spontaneous" cerebral venous thrombosis. Br Med J (Clin Res Ed) (1985) 1.58
Duplications in the DMD gene. Hum Mutat (2006) 1.58
Genetic characteristics of myoadenylate deaminase deficiency. Ann Neurol (1998) 1.57
Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology (2000) 1.57
Mapping of the locus for X-linked cardioskeletal myopathy with neutropenia and abnormal mitochondria (Barth syndrome) to Xq28. Am J Hum Genet (1991) 1.56
Interchromosomal repeat array interactions between chromosomes 4 and 10: a model for subtelomeric plasticity. Hum Mol Genet (2000) 1.56
DNA probe analysis for carrier detection and prenatal diagnosis of Duchenne muscular dystrophy: a standard diagnostic procedure. J Med Genet (1986) 1.55
Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord (2003) 1.55
FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients. J Med Genet (2004) 1.50
The postpolio syndrome: no evidence for poliovirus persistence. Ann Neurol (1992) 1.48
Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. Nat Genet (1996) 1.47
Localization of the polymorphic human calcitonin gene on chromosome 11. Hum Genet (1984) 1.46
Electrically stimulated gracilis sphincter for treatment of bladder sphincter incontinence. Lancet (1992) 1.46
Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Lancet (1999) 1.46
Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I. J Neurol Neurosurg Psychiatry (2005) 1.45
Parental origin and germline mosaicism of deletions and duplications of the dystrophin gene: a European study. Hum Genet (1992) 1.44
Radial tunnel syndrome. An investigation of compression neuropathy as a possible cause. J Bone Joint Surg Am (1991) 1.44
Ultrasonography shows extensive nerve enlargements in multifocal motor neuropathy. Neurology (2005) 1.43
Treatment of respiratory impairment in patients with motor neuron disease in the Netherlands: patient preference and timing of referral. Eur J Neurol (2013) 1.43
Facioscapulohumeral muscular dystrophy in the Dutch population. Muscle Nerve Suppl (1995) 1.43
Syncope or seizure? A matter of opinion. Clin Neurol Neurosurg (1992) 1.43
Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis. Ann Neurol (2001) 1.42
Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapy. J Neurol Neurosurg Psychiatry (2013) 1.42
Identification of the first gene (FRG1) from the FSHD region on human chromosome 4q35. Hum Mol Genet (1996) 1.42
Nerve conduction studies show no exclusive ulnar or median innervation of the ring finger. Clin Neurophysiol (1999) 1.41
Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD. Neurology (2007) 1.41